Trypsin (bovine pancreas), formic acid, trifluoroacetic acid, urea, protease inhibitor cocktail, dithiothreitol, trichloroacetic acid, acetone, and iodoacetamide were purchased from Sigma–Aldrich (St. Louis, MO, USA). Acetonitrile was ordered from Merck & Co. (Kenilworth, NJ, USA). Deionized water was purified by a Milli-Q system (Millipore, MA, USA) and all other chemicals utilized were analytical-grade.
We purchased bicinchoninic acid (BCA) protein assay kit from Beyotime Institute of Biotechnology (Tianjin, China), ProteoMiner protein enrichment kits from Bio-Rad (Hercules, CA, USA), and syringe and ultracentrifugal filters (3 kDa and10 kDa molecular weight cut-off (MWCO), respectively) from Millipore (MA, USA). Rabbit polyclonal antibodies raised against human epitopes cadherin 3, type 1, P-cadherin (placental) (CDH3; Santa Cruz Biotechnology, TX, USA), laminin, beta 2 (laminin S) (LAMB2; Santa Cruz Biotechnology, TX, USA), oxygen-regulated protein 150 kDa (Abcam, Cambridge, MA, USA), insulin-like growth factor binding protein 4 (R&D Systems, MN, USA), plasminogen activator, urokinase (PLAU; R&D Systems) were used as primary antibodies. Horseradish peroxidase-conjugated secondary antibodies or FITC-labeled fluorescent antibodies (Santa Cruz Biotechnology, TX, USA) were used as secondary antibodies for western blotting. PLAU siRNA were purchased from Santa Cruz Biotechnology (Dallas, TX, USA).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.